drugset / Trial / NCT00325962

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

NCT00325962

Phase 2 Completed 84 enrolled BioMarin Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether 6R-BH4 (sapropterin dihydrochloride) is safe and effective in the treatment of poorly controlled hypertension in the presence or absence of type 2 diabetes.

Timeline

Start
2006-05
Primary completion
2006-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject sapropterin Unknown

Indications